Proactive Investors - Run By Investors For Investors

Pacylex Pharmaceuticals CEO says its drug can eradicate cancers in 5 doses

Pacylex Pharmaceuticals, Inc CEO Michael Weickert sat down with Proactive at the Biotech Showcase in San Francisco.

The company is developing a precision medicine solution for multiple common cancers. Its approach exploits a previously-unknown therapeutic target in cancer and its diagnostic technology identifies those patients who will benefit from the drug, sparing many patients needless treatment.

 
Meet ICOx Innovations, Zynerba Pharmaceuticals, Pressure BioSciences Inc. and Alchemist Inc at our event, New York , 30 January 2019. Register here »
View full PACY profile View Profile

Pacylex Pharmaceuticals Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use